Dipal Doshi - CEO, Director at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
TRDA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Dipal Doshi - trading volume in the past year for Entrada Therapeutics, Inc.

Holdings reported by Dipal Doshi for Entrada Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 334K $5.96M $17.81 Jul 15, 2024 Direct
Stock Option (Right to Buy) 159K Mar 1, 2024 Direct Common Stock

Transactions reported by Dipal Doshi for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.